Cytox raises £2.6m to help launch Alzheimer’s test
UK precision medicine group Cytox has raised £2.6 million to fund the commercial launch and international roll out of its comprehensive testing service for Alzheimer’s disease.
Read More
Tag: genetic test
- BioMed X launches kidney disease project in partnership with the government of Barbados
- Gedeon Richter UK takes over UK rights to cariprazine
- Otsuka Pharmaceutical’s Dawnzera receives EC approval for hereditary angioedema prevention
- Corcept Therapeutics’ relacorilant plus nab-paclitaxel shows positive results in ovarian cancer
- ErVimmune raises 17m euros in funding to develop cancer vaccine
